|
W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER
|
Back to Search Results |
|
| Catalog Number |
GDSF2233 |
| Medical Device Problem Codes |
Use of Device Problem (1670); Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Codes |
Anemia (1706); Hematoma (1884); Hemorrhage/Blood Loss/Bleeding (1888)
|
| Date of Event |
02/13/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
H.6.Code c21: a review of the manufacturing records for the device is going to be conducted.The investigation is in process.The device was discarded at the facility and is not available for analysis.According to the site, the event was procedure related.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2026, the patient underwent endovascular procedure to treat a thoracoabdominal aortic aneurysm using a gore® excluder® thoracoabdominal branch endoprosthesis (tambe) device system.A gore® dryseal flex introducer sheath was used for access.On (b)(6) 2026, the patient experienced 500 ml blood loss and an acute post-op blood loss anemia and had a blood transfusion treatment in operating room.On (b)(6) 2026, a left axillary hematoma was noticed.Based on the study data, the event was potentially related to dryseal flex introducer sheath and was fixed during the initial procedure.According to the physician, the patient didn¿t have a significant amount of blood loss.Preoperatively, hgb was low and we transfused to keep hgb >9.Transfusion was not due to blood loss.According to the site, hematoma was caused by the accessory device.100 ml blood loss was from evacuated hematoma at left axillary and was caused by the accessory device.Based on the information provided, it was uncertain where additional 400ml blood loss originated from.Documented in op note ebl = total of 500 ml.The event was resolved.According to the site, it was procedure related.The patient tolerated the procedure and discharged home in stable condition.
|
| |
|
Additional Manufacturer Narrative
|
|
H6: code c19: a review of the manufacturing records indicated the lot met pre-release specifications.The sheath was discarded at the facility and is not available for analysis.According to the site, the event was procedure related.According to the site, hematoma was caused by the accessory device, however there was no vessel damage/trauma reported.100 ml blood loss was from evacuated hematoma at left axillary and was caused by the accessory device.The patient experienced 500 ml blood loss.It was uncertain where additional 400 ml blood loss originated from.
|
| |
|
Search Alerts/Recalls
|
|
|